CAS No. |
2216703-12-5 |
中文名称 |
4'-(((R)-6-(((R,Z)-6,11-双[(叔丁氧羰基)氨基]-2,2-二甲基-4,12-二氧代-3,16-二氧杂-5,7,13-三氮杂十八-5-烯-18-基)氧基)-1-甲基-1-(2-氧代-2-(噻唑-2-基氨基)乙基)-1,2,3,4-四氢异喹啉-7-基)氧基)-2'-氟-[1,1'-联苯]-4-羧酸 |
英文名称 |
4'-(((R)-6-(((R,Z)-6,11-Bis((tert-butoxycarbonyl)amino)-2,2-dimethyl-4,12-dioxo-3,16-dioxa-5,7,13-triazaoctadec-5-en-18-yl)oxy)-1-methyl-1-(2-oxo-2-(thiazol-2-ylamino)ethyl)-1,2,3,4-tetrahydroisoquinolin-7-yl)oxy)-2'-fluoro-[1,1'-biphenyl]-4-carboxylic acid |
别名 |
13-Oxa-2,4,10-triazapentadec-2-enoic acid, 15-[[(1R)-7-[(4'-carboxy-2-fluoro[1,1'-biphenyl]-4-yl)oxy]-1,2,3,4-tetrahydro-1-methyl-1-[2-oxo-2-(2-thiazolylamino)ethyl]-6-isoquinolinyl]oxy]-3,8-bis[[(1,1-dimethylethoxy)carbonyl]amino]-9-oxo-, 1-(1,1-dimethylethyl) ester, (2Z,8R)-;PCSK9 ligand 1 |
标准英文名 |
4'-(((R)-6-(((R)-6,11-bis((tert-butoxycarbonyl)amino)-2,2-dimethyl-4,12-dioxo-3,16-dioxa-5,7,13-triazaoctadec-6-en-18-yl)oxy)-1-methyl-1-(2-oxo-2-(thiazol-2-ylamino)ethyl)-1,2,3,4-tetrahydroisoquinolin-7-yl)oxy)-2'-fluoro-[1,1'-biphenyl]-4-carboxylic acid |
分子式 |
C53H69FN8O13S |
分子量 |
1077.24
|
精确分子量 |
1076.47
|
SMILES |
CC(C)(C)OC(=O)NC(=NCCC[C@@H](NC(=O)OC(C)(C)C)C(=O)NCCOCCOC1=C(OC2=CC(F)=C(C3=CC=C(C(=O)O)C=C3)C=C2)C=C2C(=C1)CCN[C@]2(C)CC(=O)NC1=NC=CS1)NC(=O)OC(C)(C)C |
标准SMILES |
C[C@]1(CC(=O)NC2=NC=CS2)NCCC2=CC(OCCOCCNC(=O)[C@@H](CCCN=C(NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)NC(=O)OC(C)(C)C)=C(C=C12)OC1=CC(F)=C(C=C1)C1C=CC(=CC=1)C(O)=O |
用途 |
PCSK9 ligand with high affinity (Ki = 107 nM); modulates protein-protein interaction between PCSK9 and low-density lipoprotein receptor (LDLR). |
InChIKey |
BOAJXEFAPWTSFX-ROXLDNMXSA-N |